Search

everythinglearnresearchcommunity

for

Search:↓

Increasing PBX1 reduces aging and cell death in hair follicle stem cells by boosting SIRT1 and lowering PARP1 activity.

Both 1565-nm laser and 1064-nm laser safely and effectively reduce enlarged facial pores, with the 1064-nm laser causing fewer side effects.

PCOS is often linked to insulin resistance and obesity, and weight loss can improve symptoms.

Changing the diagnosis criteria for PCOS might miss women at risk for related health issues.

A postmenopausal woman's masculine symptoms improved after surgery for a hormone-producing ovarian tumor.

Treating early puberty with hormone therapy may increase the risk of polycystic ovary syndrome in adults.

Liposomes show promise for delivering CRISPR for gene editing but face challenges like delivery efficiency and safety concerns.

Removing an adrenal tumor can significantly reduce high androgen levels in postmenopausal women.

Nanocarriers could improve how drugs are delivered through the skin but require more research to overcome challenges and ensure safety.

Prostate cancer can progress even with low testosterone due to internal hormone production in the tumor.

Researchers developed a nanomedicine for acne treatment that delivers medication with less irritation and is non-irritating for oily skin.

Women with PCOS are more likely to have fatty liver disease and worse metabolic health.

PCOS patients have more central body fat, which can be effectively measured using DEXA.

LC-OCT helps accurately diagnose different types of infant hair loss without invasive methods.

PCOS is a complex condition that affects women's hormonal balance and metabolism, requiring lifestyle changes and medical management.

The study concludes that early diagnosis of Frontal Fibrosing Alopecia is important, as it is often found in postmenopausal women, may be related to Lichen Planopilaris, and eyebrow hair loss is a common sign.

PCOS is managed by lifestyle changes and personalized medication to improve symptoms and fertility.

Depression in women with Polycystic Ovarian Syndrome (PCOS) is linked to insulin resistance and hyperandrogenism, and managing these can help reduce depression. Lifestyle changes and Cognitive Behavioral Therapy can be effective treatments.

Using Platelet-Rich Plasma and Adipose-Derived Mesenchymal Stem Cells together can improve healing, including wound healing, bone regeneration, and hair growth.

Cross-sex hormone therapy is important for managing gender dysphoria and requires careful monitoring and healthcare provider education.

Finasteride may help treat hidradenitis suppurativa in children, but concerns exist about ethics, safety, and proper use.

A 71-year-old woman developed male-like features due to high testosterone levels caused by a benign ovarian tumor, which was successfully removed by surgery.

The conclusion is that thorough investigation of hypertension and hormonal dysfunctions is important, and there may be a link between these conditions and cancer.

GnRH analogues are effective for diagnosing and treating female androgen excess, offering a non-surgical option.

Overweight women with PCOS have higher levels of certain hormones that could indicate a higher risk of heart and metabolic problems.

Most women with PCOS have insulin resistance, especially those with phenotype B.

The document concludes that effectively managing PCOS requires a multifaceted approach.

The document concludes that specific dermoscopic features can help diagnose different facial red skin conditions.

Excess male hormones in postmenopausal women can cause health issues and increase the risk of heart disease and diabetes; treatment depends on the cause.

Hispanic women with PCOS are more likely to have liver diseases like NAFLD and NASH.